Estourgie Susanne H, Nieweg Omgo E, Valdés Olmos Renato A, Th Rutgers Emiel J, Kroon Bin B R
Departments of Surgery, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
Clin Nucl Med. 2003 May;28(5):371-4. doi: 10.1097/01.RLU.0000063409.68758.D4.
A 1.5-cm nonpalpable mass was detected in the upper outer quadrant of the left breast by screening mammography in a 55-year-old woman. The patient was scheduled for a sentinel node procedure, and lymphoscintigraphy was performed the day before surgery. Unintentionally, she received an intraparenchymal tracer injection 3 cm away from the malignant lesion instead of the intended intratumoral injection. Lymphoscintigraphy revealed two sentinel nodes in the axilla. A second dose of Tc-99m nanocolloid was injected the next day into the primary tumor through a catheter that had been inserted under ultrasound guidance the previous day. Once more, a lymphoscintigraphic image was obtained that showed additional sentinel nodes in two different regions outside the axilla. This observation supports the authors' contention that lymphatic watersheds exist in the breast and highlights the importance of tracer administration into or close to the tumor.
在对一名55岁女性进行乳腺筛查钼靶检查时,在左乳外上象限发现一个1.5厘米、触诊不到的肿块。该患者计划进行前哨淋巴结手术,术前一天进行了淋巴闪烁显像。意外的是,她在距恶性病变3厘米处进行了实质内示踪剂注射,而非预期的瘤内注射。淋巴闪烁显像显示腋窝有两个前哨淋巴结。次日,通过前一天在超声引导下插入的导管,将第二剂锝-99m纳米胶体注入原发肿瘤。再次获得的淋巴闪烁显像图像显示腋窝外两个不同区域有额外的前哨淋巴结。这一观察结果支持了作者关于乳腺存在淋巴分水岭的观点,并突出了将示踪剂注入肿瘤内或肿瘤附近的重要性。